• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 2002년도 제11차 추계학술대회
• /
• pp.6-6
• /
• 2002

• 한국식품영양과학회지
• /
• 제38권12호
• /
• pp.1724-1731
• /
• 2009

마카, 홍삼, 남가새 추출물을 일정한 무게 비율로 혼합하여 발효시켜 얻어진 식물추출복합발효물(MP119)이 성기능에 미치는 영향을 조사하였다. ACE(angiotensin converting enzyme)과 PDE(phosphodiesterase)에 대한 저해효과를 통해 혈액순환부진 개선 및 cGMP 농도에 의한 발기능 개선에 미치는 효과를 측정하였다. MP119의 ACE 저해효과를 측정한 결과 $IC_{50}$값이 241.3${\pm}$35.5 ppm, PDE 저해효과를 측정한 결과 $IC_{50}$값이 372.2${\pm}$33.8 ppm으로 나타나 혈관확장으로 인한 혈류량 증가 및 cGMP농도 증가에 영향을 줄 수 있을 것으로 예상된다. MP119는 마우스 정소세포인 TM3 cell에 유의성 있는 독성이 나타나지 않았으며, TM3 cell에 농도별로 처리했을 때 세포배양액으로부터 대조군과 비교하여 최대 20.11% 증가한 testosterone 농도를 확인하였다. 또한 HUVEC에 농도별로 처리했을 때 NO생산량이 MP119 처리 농도가 증가할수록 유의성 있게 증가하였다. 웅성마우스에 MP119를 7일간 경구투여 후 생식장기의 무게와 정자수를 측정하고, MP119를 경구투여한 후 염화카드뮴을 투여하여 생식장기의 무게와 정자수를 측정하였다. 또한 실험쥐로부터 혈청을 분리하여 혈청 내 testosterone과 cGMP를 측정하였다. 그 결과 MP119의 투여를 통해 생식장기의 무게 변화 없이 정자수 증가에 도움을 준다는 것을 확인하였으며, 더불어 혈청 내 testosterone 및 cGMP의 농도 역시 증가하였다. MP119를 투여한 후 염화카드뮴을 투여한 실험군에서 역시 정자수 및 혈청 내 testosterone, cGMP 농도 증가를 나타내었으므로 결과적으로 MP119가 염화카드뮴의 독성예방 및 치료에 효과적임을 확인하였다.

• 약학회지
• /
• 제36권3호
• /
• pp.259-268
• /
• 1992

A procedure for the determination of KR-30075 and its metabolites in plasma and urine by high performance liquid chromatography is described. For the study of pharmacokinetic properties of KR-30075, a new PDE III inhibitor, the plasma concentration and urinary excretion after an oral administration of KR-30075 (4 mg/kg) in the male rat (Sprague Dawley) were determined by high performance liquid chromatography. The best extraction efficiency of KR-30075 and KR-30072 is obtained with ethyl ether adjusted to pH 4.0. Retention times of both KR-30072 and KR-30075 were within 5 min and resolution was complete at the flow rate of 1.0 ml/min. The sensitivity and specificity of this HPLC assay appears to be satisfactory for the pharmacokinetic study of KR-30075 and its metabolites. One-compartment open model with first-order absorption was applied to evaluate the pharmacokinetic parameters of KR-30075 according to Minimum AIC Estimation. $T_{max}$ was 1 hr, $C_{max}$ was $0.789{\pm}0.31\;{\mu}g/ml$ and elimination half $T_{1/2}$ was 6.31 min after oral administration of 4 mg/kg KR-30075 to male rats.

• 한국통신학회논문지
• /
• 제28권5C호
• /
• pp.539-547
• /
• 2003

PDE기법에 기반한 움직임 추정에서는 SAD가 누적 초기에 큰 값을 가지는 것이 이상적이다. 이를 위해 본 논문에서는 새로운 누적 순서 및 탐색 순서를 결합한 효율적인 블록 정합 방식을 제안한다. 제안하는 누적 순서는 현재 블록에서 고주파 성분이 큰 영역에 대하여 SAD 계산이 먼저 수행되도록 한다. 또한, 제안하는 탐색 순서는 현재 블록과 각 후보 블록간의 DC차와 SAD간의 연관성에 기반하여, 낮은 DC차를 지니는 후보 블록을 먼저 정합되도록 하였다. 모의 실험 결과는 제안 방식에 의하여 약 6%의 성능 향상이 이루어짐을 보여준다.

• 천문학회보
• /
• 제37권2호
• /
• pp.210.1-210.1
• /
• 2012

We report technique used for improved measurement uncertainties for Photon detection efficiency(PDE) of $1mm^2$ single pixel SiPM. It consists of 470nm LED light source, two 2-inch integrating sphere and two NIST calibrated silicon photodiodes that have ${\pm}2.4%$ calibration error. With raytracing simulation of our experimental setup, we predict number of photon into SiPM and measurement uncertainty. For MPPC, Hamamatsu suggested PDE(1600 micro pixel) including crosstalk and afterpulse is 23.5% at 470 nm. By using new low calibration error photodiode and raytracing simulation, our simulation result has ${\pm}3%$ measurement uncertainty. The technical detail of measurement, simulation are presented with the results and implication.

• 한국환경과학회지
• /
• 제21권5호
• /
• pp.563-572
• /
• 2012

Unlike water applications, the photocatalytic technique utilizing light-emitting-diodes as an alternative light source to conventional lamp has rarely been applied for low-level indoor air purification. Accordingly, this study investigated the applicability of UV-LED to annular-type photocatalytic reactor for removal of indoor-level benzene and toluene at a low concentration range associated with indoor air quality issues. The characteristics of photocatalyst was determined using an X-ray diffraction meter and a scanning electron microscope. The photocatalyst baked at $350^{\circ}C$ exhibited the highest photocatalytic degradation efficiencies(PDEs) for both benzene and toluene, and the photocatalysts baked at three higher temperatures(450, 550, and $650^{\circ}C$) did similar PDEs for these compounds. The average PDEs over a 3-h period were 81% for benzene and close to 100% for toluene regarding the photocatalyst baked at $350^{\circ}C$, whereas they were 61 and 74% for benzene and toluene, respectively, regarding the photocatalyst baked at $650^{\circ}C$. As the light intensity increased from 2.4 to 3.5 MW $cm^{-1}$, the average PDE increased from 36 to 81% and from 44% to close to 100% for benzene and toluene, respectively. In addition, as the flow rate increased from 0.1 to 0.5 L $min^{-1}$, the average PDE decreased from 81% to close to zero and from close to 100% to 7% for benzene and toluene, respectively. It was found that the annular-type photocatalytic reactor inner-inserted with UV-LEDs can effectively be applied for the decomposition of low-level benzene and toluene under the operational conditions used in this study.

• The Korean Journal of Physiology and Pharmacology
• /
• 제22권5호
• /
• pp.577-584
• /
• 2018

Bladder dysfunction is a common complication of diabetes mellitus (DM). However, there have been a few studies evaluating bladder smooth muscle contraction in DM in the presence of pharmacological inhibitors. In the present study, we compared the contractility of bladder smooth muscle from normal rats and DM rats. Furthermore, we utilized pharmacological inhibitors to delineate the mechanisms underlying bladder muscle differences between normal and DM rats. DM was established in 14 days after using a single injection of streptozotocin (65 mg/kg, intraperitoneal) in Sprague-Dawley rats. Bladder smooth muscle contraction was induced electrically using electrical field stimulation consisting of pulse trains at an amplitude of 40 V and pulse duration of 1 ms at frequencies of 2-10 Hz. In this study, the pharmacological inhibitors atropine (muscarinic receptor antagonist), U73122 (phospholipase C inhibitor), DPCPX (adenosine $A_1$ receptor antagonist), udenafil (PDE5 inhibitor), prazosin (${\alpha}_1$-receptor antagonist), verapamil (calcium channel blocker), and chelerythrine (protein kinase C inhibitor) were used to pretreat bladder smooth muscles. It was found that the contractility of bladder smooth muscles from DM rats was lower than that of normal rats. In addition, there were significant differences in percent change of contractility between normal and DM rats following pretreatment with prazosin, udenafil, verapamil, and U73122. In conclusion, we suggest that the decreased bladder muscle contractility in DM rats was a result of perturbations in $PLC/IP_3$-mediated intracellular $Ca^{2+}$ release and PDE5 activity.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2002년도 창립10주년기념 및 국립독성연구원 의약품동등성평가부서 신설기념 국재학술대회:생물학적 동등성과 의약품 개발 전략을 위한 국제심포지움
• /
• pp.208-208
• /
• 2002

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2002년도 창립10주년기념 및 국립독성연구원 의약품동등성평가부서 신설기념 국재학술대회:생물학적 동등성과 의약품 개발 전략을 위한 국제심포지움
• /
• pp.232-232
• /
• 2002

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2002년도 창립10주년기념 및 국립독성연구원 의약품동등성평가부서 신설기념 국재학술대회:생물학적 동등성과 의약품 개발 전략을 위한 국제심포지움
• /
• pp.223-223
• /
• 2002